United States · FDA National Drug Code directory
RESTASIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0023-9163_3b350ae7-28e6-4dbd-824c-d0fe46b81e5a
- Product NDC
- 0023-9163
- Form
- EMULSION
- Composition / generic term
- cyclosporine
- Labeler
- Allergan, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20030401
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOSPORINE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 VIAL, SINGLE-USE in 1 CARTON (0023-9163-12) / .4 mL in 1 VIAL, SINGLE-USE · 0023-9163-12
- 30 VIAL, SINGLE-USE in 1 TRAY (0023-9163-30) / .4 mL in 1 VIAL, SINGLE-USE · 0023-9163-30
- 60 VIAL, SINGLE-USE in 1 TRAY (0023-9163-60) / .4 mL in 1 VIAL, SINGLE-USE · 0023-9163-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →